Podcast appearances and mentions of helen mcshane

  • 11PODCASTS
  • 11EPISODES
  • 12mAVG DURATION
  • ?INFREQUENT EPISODES
  • Jan 17, 2019LATEST

POPULARITY

20172018201920202021202220232024


Latest podcast episodes about helen mcshane

National Institute for Health and Care Research
Clinical Trials Of Vaccines With Prof. Helen McShane

National Institute for Health and Care Research

Play Episode Listen Later Jan 17, 2019 10:42


Clinical Trials Of Vaccines With Prof. Helen McShane

Future Science Group
IDHTalks with Helen McShane: Developing a new tuberculosis vaccine

Future Science Group

Play Episode Listen Later May 25, 2017 12:28


Helen McShane discusses her work leading the TB vaccine research program at Oxford University, and shares her thoughts on the challenges facing vaccine development and eradication of this disease.

Career Equality Talks
Helen McShane: Women in science

Career Equality Talks

Play Episode Listen Later Dec 10, 2014 23:03


A career in juggling, organisation and guilt management Professor Helen McShane has been working on a new TB vaccine for 10 years. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. She developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

Career Equality Talks
Helen McShane: Women in science

Career Equality Talks

Play Episode Listen Later Dec 10, 2014 23:03


A career in juggling, organisation and guilt management Professor Helen McShane has been working on a new TB vaccine for 10 years. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. She developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

Women in Medical Science
Helen McShane: Women in science

Women in Medical Science

Play Episode Listen Later Oct 7, 2014 23:03


A career in juggling, organisation and guilt management Professor Helen McShane has been working on a new TB vaccine for 10 years. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. She developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

The Lancet
The Lancet: February 04, 2013

The Lancet

Play Episode Listen Later Feb 4, 2013 10:40


Helen McShane from the University of Oxford discusses results from a phase IIb tuberculosis trial.

Microbe Talk
TB vaccines - tackling a global killer

Microbe Talk

Play Episode Listen Later Mar 23, 2012 17:02


What are the best ways to control the global problem of tuberculosis? Professor Helen McShane from the Jenner Institute tells us about the MVA85A tuberculosis vaccine from her lab that’s currently undergoing large-scale clinical trials and the impact it could have on the incidence of TB around the world. This episode of Microbe Talk has been produced for World TB Day on Saturday 24 March.

Translational Medicine
Tuberculosis

Translational Medicine

Play Episode Listen Later Mar 1, 2011 3:54


Dr Helen McShane has been working on a new TB vaccine for 10 years. She explains why developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. Dr Helen McShane developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. BCG, now over 100 years old, remains the only licensed vaccine against Tuberculosis. It confers good protection against severe disease and meningitis but doesn't protect against lung disease. MVA85A was the first vaccine of the new generation to enter into efficacy testing. It is currently being tested in The Gambia, Senegal and South Africa.

Epidemics and Vaccines
Tuberculosis

Epidemics and Vaccines

Play Episode Listen Later Mar 1, 2011 3:54


Professor Helen McShane talks about her work on a new vaccine against tuberculosis. There are about 9 million new cases and two million deaths every year from tuberculosis (TB). BCG, now over 100 years old, remains the only licensed vaccine against TB. It confers good protection against severe disease and meningitis, but doesn't protect against lung disease. After working on TB for 10 years, Professor Helen McShane developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Professor McShane explains why developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

Translational Medicine
Tuberculosis

Translational Medicine

Play Episode Listen Later Mar 1, 2011 3:54


Dr Helen McShane has been working on a new TB vaccine for 10 years. She explains why developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. Dr Helen McShane developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. BCG, now over 100 years old, remains the only licensed vaccine against Tuberculosis. It confers good protection against severe disease and meningitis but doesn't protect against lung disease. MVA85A was the first vaccine of the new generation to enter into efficacy testing. It is currently being tested in The Gambia, Senegal and South Africa.

Vaccine Research at Oxford
Fighting to end Tuberculosis

Vaccine Research at Oxford

Play Episode Listen Later Nov 10, 2009 4:53


Helen McShane and Dr Helen Fletcher talk about a new TB vaccine currently being developed at Oxford's Wellcome Trust Centre that could become a more effective vaccine against Tuberculosis.